About
This program provides a comprehensive guide to pharmaceutical innovation and medical strategy tailored for the Canadian market. It focuses on the essential pillars of medical affairs, including MSL excellence, rare disease launch advisory, and cross-functional integration. Participants will learn how to bridge the gap between science and strategy to ensure successful market entry and stakeholder alignment. The curriculum provides professional insights into evidence generation, market readiness, and operational leadership for biotech firms.
You can also join this program via the mobile app. Go to the app
Price
Free